
Sequencer As A Service Market Report 2026
Global Outlook – By Component (Software, Hardware, Services), By Service Type (Sample Preparation Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Analysis Services, Data Storage And Management Services, Integrated End-to-End Sequencing Services), By Deployment Mode (Cloud-Based, On-Premises), By Application (Clinical Diagnostics, Oncology Research, Rare Disease Research, Infectious Disease Surveillance, Drug Discovery And Development, Agrigenomics, Forensic Genomics, Reproductive Health Testing, Personalized Medicine Research), By End-User (Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Academic Institutions, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Sequencer As A Service Market Overview
• Sequencer As A Service market size has reached to $2.31 billion in 2025 • Expected to grow to $5.73 billion in 2030 at a compound annual growth rate (CAGR) of 20% • Growth Driver: Increasing Prevalence Of Genetic Disorders Fueling The Growth Of The Market Due To Rising Demand For Early Detection And Accurate Genomic Diagnosis • Market Trend: Integration Of Artificial Intelligence-Driven Bioinformatics Platforms And Certified Service Provider Accreditation Initiatives In Sequencer-As-A-Service (Saas) Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Sequencer As A Service Market?
Sequencer as a service is a business model in which genomic sequencing capabilities are provided to customers on a contractual or pay-per-use basis rather than through the purchase of sequencing equipment. It enables organizations to access advanced DNA and RNA sequencing technologies, laboratory infrastructure, and bioinformatics analysis without investing in in-house platforms. This model reduces capital expenditure, improves scalability, and accelerates research, diagnostics, and innovation by delivering end-to-end sequencing solutions through specialized providers. The main components of sequencer as a service include software, hardware, and services. Software refers to platforms that manage sequencing workflows, data analysis, and reporting for end-to-end genomics solutions. The service types include sample preparation services, library preparation services, sequencing execution services, bioinformatics analysis services, data storage and management services, and integrated end-to-end sequencing services and are deployed through cloud-based and on-premises modes. The various applications involved are clinical diagnostics, oncology research, rare disease research, infectious disease surveillance, drug discovery and development, agrigenomics, forensic genomics, reproductive health testing, and personalized medicine research, and are used by several end users such as hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, academic institutions, and other end users.
What Is The Sequencer As A Service Market Size and Share 2026?
The sequencer as a service market size has grown rapidly in recent years. It will grow from $2.31 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to rising demand for genomic research, limited access to in-house sequencing platforms, high cost of sequencing instruments, growth in personalized medicine initiatives, increasing collaborations between research institutes and sequencing providers.What Is The Sequencer As A Service Market Growth Forecast?
The sequencer as a service market size is expected to see exponential growth in the next few years. It will grow to $5.73 billion in 2030 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to adoption of cloud-based sequencing solutions, demand for high-throughput sequencing services, integration of ai-driven bioinformatics analysis, expansion of clinical genomics applications, increasing outsourcing of sequencing services. Major trends in the forecast period include cloud-based sequencing services, automated sample preparation, integrated bioinformatics solutions, pay-per-use sequencing models, scalable genomic data management.Global Sequencer As A Service Market Segmentation
1) By Component: Software, Hardware, Services 2) By Service Type: Sample Preparation Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Analysis Services, Data Storage And Management Services, Integrated End-to-End Sequencing Services 3) By Deployment Mode: Cloud-Based, On-Premises 4) By Application: Clinical Diagnostics, Oncology Research, Rare Disease Research, Infectious Disease Surveillance, Drug Discovery And Development, Agrigenomics, Forensic Genomics, Reproductive Health Testing, Personalized Medicine Research 5) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Academic Institutions, Other End Users Subsegments: 1) By Software: Bioinformatics Analysis Platforms, Sequence Data Management Systems, Variant Interpretation Tools, Workflow Automation Software, Cloud-Based Data Processing Platforms 2) By Hardware: High Throughput Sequencing Instruments, Sample Preparation Systems, Laboratory Automation Equipment, Data Storage Servers, High Performance Computing Infrastructure 3) By Services: Sample Processing Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Interpretation Services, Data Storage And Management Services, Consulting And Technical Support ServicesWhat Is The Driver Of The Sequencer As A Service Market?
The increasing prevalence of genetic disorders is expected to propel the growth of the sequencer as a service market going forward. Genetic disorders refer to medical conditions caused by abnormalities in an individual's deoxyribonucleic acid, inherited from one or both parents or arising from new mutations. The increasing genetic disorders are increasing due to rising parental age, as older parents have a higher risk of passing on genetic mutations to their children. Sequencer as a service helps address genetic disorders by providing scalable and on-demand access to advanced DNA and RNA sequencing technologies, enabling early detection and accurate diagnosis. It reduces infrastructure and operational burdens for laboratories and healthcare providers by offering cloud-based data analysis and expert support, improving precision medicine outcomes and research efficiency. For instance, in May 2024, according to the National Health Service, a UK-based government department, there are 17,000 people living with sickle cell disease, an inherited genetic blood disorder, with around 250 new cases diagnosed each year. Therefore, the increasing prevalence of genetic disorders is driving the growth of the sequencer as a service industry.Key Players In The Global Sequencer As A Service Market
Major companies operating in the sequencer as a service market are Admera Health, ArrayGen Technologies, BGI Genomics Co. Ltd., CD Genomics Inc., Element Biosciences, Eurofins Scientific SE, Gene by Gene, GENEWIZ Germany GmbH, Illumina Inc., Karkinos Healthcare, Lucigen, Macrogen Inc., MedGenome Labs Ltd., Novogene Co. Ltd., Quest Diagnostics, SeqMatic LLC, SeqWell, Strand Life Sciences Pvt. Ltd., Veritas Genetics, Yaazh Xenomics.Global Sequencer As A Service Market Trends and Insights
Major companies operating in the sequencer as a service market are focusing on integrating artificial intelligence-driven bioinformatics platforms, such as certified provider accreditation initiative, to enhance service quality, technical compliance, and standardized workflow efficiency across genomics and single-cell analysis applications. Certified provider accreditation initiative refers to a structured program in which an organization formally recognizes and authorizes external service providers or partners who meet predefined standards of technical expertise, operational quality, and compliance. For instance, in July 2024, Parse Biosciences, a Seattle-based provider of single-cell sequencing solutions, launched its Certified Service Provider Program to broaden access to scalable single-cell analysis. The program enables researchers to collaborate with accredited providers such as SeqMatic and Eurofins Clinical Enterprise, who deliver end-to-end workflows including Evercode Whole Transcriptome, Evercode TCR, CRISPR Detect, Gene Capture, and Evercode BCR, capturing full-length BCR sequences alongside gene expression at high throughput. This initiative ensures expert sample handling, workflow standardization, and high-quality results making it ideal for both pilot studies and routine large-scale single-cell projects.What Are Latest Mergers And Acquisitions In The Sequencer As A Service Market?
In February 2026, Swiss Rockets AG, a Switzerland-based life sciences venture builder, acquired Complete Genomics Inc. for an undisclosed amount. Through this acquisition, Swiss Rockets AG aims to strengthen its biotechnology development portfolio, accelerate precision medicine innovation, and expand global sequencing technology capabilities. Complete Genomics Inc. is a US-based genomics company that is involved in the sequencer-as-a-service model by offering outsourced sequencing services alongside selling its proprietary DNBSEQ™ instruments.Regional Insights
North America was the largest region in the sequencer as a service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Sequencer As A Service Market?
The sequencer as a service market includes revenues earned by entities through on-demand genomic sequencing solutions, laboratory processing, transcriptome sequencing services, and cloud-based genomic data management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Sequencer As A Service Market Report 2026?
The sequencer as a service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sequencer as a service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Sequencer As A Service Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.76 billion |
| Revenue Forecast In 2035 | $5.73 billion |
| Growth Rate | CAGR of 19.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Service Type, Deployment Mode, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Admera Health, ArrayGen Technologies, BGI Genomics Co. Ltd., CD Genomics Inc., Element Biosciences, Eurofins Scientific SE, Gene by Gene, GENEWIZ Germany GmbH, Illumina Inc., Karkinos Healthcare, Lucigen, Macrogen Inc., MedGenome Labs Ltd., Novogene Co. Ltd., Quest Diagnostics, SeqMatic LLC, SeqWell, Strand Life Sciences Pvt. Ltd., Veritas Genetics, Yaazh Xenomics. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
